• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER INC QDOT MICRO¿ CATHETER; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER INC QDOT MICRO¿ CATHETER; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION Back to Search Results
Catalog Number D139504
Device Problem Patient Device Interaction Problem (4001)
Patient Problem Heart Block (4444)
Event Date 01/16/2024
Event Type  Injury  
Event Description
It was reported that a patient underwent an idiopathic ventricular tachycardia (idvt) - right ablation with a qdot micro¿ catheter and the patient experienced a complete heart block that required a pacemaker.It was reported that during an idvt right-sided case, a complete heart block was noticed.The complete heart block was discovered by the intracardiac electrocardiogram (ecg) signals.Temporary pacing with the ablation catheter was done until permanent pacing system could be implanted.The physician's opinion on the cause of this adverse event was that it was procedure related.Intervention included temporary pacing via cs catheter, ultimately permanent pacemaker placement.The patient has fully recovered.
 
Manufacturer Narrative
If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Manufacturer's reference number: (b)(4).
 
Manufacturer Narrative
It was reported that a patient underwent an idiopathic ventricular tachycardia (idvt) - right ablation with a qdot micro¿ catheter and the patient experienced a complete heart block that required a pacemaker.It was reported that during an idvt right-sided case, a complete heart block was noticed.The complete heart block was discovered by the intracardiac electrocardiogram (ecg) signals.Temporary pacing with the ablation catheter was done until permanent pacing system could be implanted.The physician's opinion on the cause of this adverse event was that it was procedure related.Intervention included temporary pacing via cs catheter, ultimately permanent pacemaker placement.The patient has fully recovered.Device evaluation details: the product was returned to biosense webster (bwi) for evaluation.A visual inspection and revision of all features were performed following bwi procedures.Visual analysis revealed no damage or anomalies on the device.The device features were reviewed, and no issues were observed during the product investigation.A manufacturing record evaluation was performed for the finished device number lot 31181925l, and no internal action related to the complaint was found during the review.Additionally, the manufacture and expiration dates have been provided.Therefore, fields d4.Expiration date and h4.Device manufacture date have been populated.No malfunction was observed during the product analysis.The physician's opinion on the cause of this adverse event was the procedure.The root cause of the adverse event remains unknown.In addition, no device malfunction was reported.There may have been other circumstances or issues that occurred during the use of the device that could not be replicated during the analysis.The instruction for use (ifu) states that careful catheter manipulation must be performed to avoid cardiac damage, perforation, or tamponade.As part of biosense webster¿s quality process, all devices are manufactured, inspected, and released to approved specifications.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
QDOT MICRO¿ CATHETER
Type of Device
CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION
Manufacturer (Section D)
BIOSENSE WEBSTER INC
31 technology drive, suite 200
irvine CA 92618
Manufacturer (Section G)
BIOSENSE WEBSTER INC (JUAREZ)
circuito interior norte
1820parque industrial salvacar
juarez 32599
MX   32599
Manufacturer Contact
kate karberg
31 technology dr
irvine, CA 92618
3035526892
MDR Report Key18660519
MDR Text Key334777245
Report Number2029046-2024-00412
Device Sequence Number1
Product Code OAE
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P210027
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/20/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/07/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberD139504
Device Lot Number31181925L
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/26/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured11/05/2023
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
BIDIRECTIONAL CS CATHETER; GE SOUNDSTAR CATHETER; NGEN GENERATOR; OCTARAY CATHETER; VIZIGO BIDIRECTIONAL SHEATH
Patient Outcome(s) Required Intervention;
Patient SexFemale
-
-